DEEPSEEK
Protai Leverages NVIDIA NIM and AlphaFold for Enhanced Protein Structure Prediction
Protai advances drug discovery by integrating NVIDIA NIM with AlphaFold and proteomics, optimizing protein structure predictions for precision medicine.
GenMol: A New Frontier in Molecular Generation for Drug Discovery
Explore GenMol, a generalist foundation model for molecular generation, and its advantages over SAFE-GPT in the realm of AI-driven drug discovery.
NVIDIA Introduces BioNeMo Blueprint to Revolutionize Protein Binder Design
NVIDIA unveils the BioNeMo Blueprint, a new AI-powered approach to accelerate protein binder design in drug discovery, leveraging GPU-accelerated microservices.
NVIDIA Launches cuEquivariance to Revolutionize AI in Drug and Material Discovery
NVIDIA introduces cuEquivariance, a new math library aimed at enhancing AI models for scientific discovery, addressing challenges in symmetry transformations and computational efficiency.
Mitsui & Co's Xeureka Utilizes NVIDIA AI for Secure Drug Discovery
Xeureka, a subsidiary of Mitsui & Co, leverages NVIDIA's AI platform to safely share healthcare data, enhancing drug discovery efforts through advanced confidential computing.
Binance Pay Offers 11% Discount on Mobile Top-ups with No Minimum Spend
Binance Pay users can avail an 11% discount on mobile top-ups with no minimum spend, applicable in selected regions on a first-come, first-served basis, capped at 2 USDT per user.
AI-Driven Drug Discovery Revolutionizes Treatment Development
AI's integration into drug discovery is transforming the development of treatments, reducing time and cost significantly, according to NVIDIA's blog.
NVIDIA's GPU Innovations Revolutionize Drug Discovery Simulations
NVIDIA's latest GPU optimization techniques, including CUDA Graphs and C++ coroutines, promise to accelerate pharmaceutical research by enhancing molecular dynamics simulations.
AI Foundation Models Propel Scientific Discovery Forward
Microsoft's AI foundation models, such as MatterGen and Aurora, are enhancing scientific research by accelerating materials discovery and improving weather predictions.
Yale, Moderna, and NVIDIA Harness Quantum Computing for Drug Discovery
Yale, Moderna, and NVIDIA explore quantum machine learning to enhance drug discovery. The collaboration focuses on GPU-accelerated simulation of quantum algorithms for predicting molecular properties.